Primary record
Leflunomide; 5-Methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide; Arava; HWA 486; Leflunomida; Leflunomidum; SU 101
- 库存
- 4,136 克
- 纯度
- 99.4 %
- CAS
- 75706-12-6
化合物标识与属性
- CAS
- 75706-12-6
- PubChem CID
- 3899
- SMILES
- CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
- Canonical SMILES
- Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1
名称与同义词
- leflunomide
- Arava
- 75706-12-6
- Leflunomida
- Leflunomidum
- lefunamide
- Repso
- leflunomide medac
- Leflunomide teva
- Leflunomid
- avara
- lefumide
- Leflunomide-d4
- Arabloc
- Leflunomide winthrop
- Leflunomidum [INN-Latin]
- SULOL
- Leflunomide CRS
- Leflunomide ratiopharm
- Arava (TN)
- HWA-486
- Leflunomide [INN]
- Leflunomide Apotex
- Isoxazol lefunomide
- Prestwick_87
- Arava, Leflunomide
- Leflunomide Actavis
- HWA 486
- Leflunomida [INN-Spanish]
- SU 101 (pharmaceutical)
- Lefunomide [Inn-Spanish]
- Leflunomide [USAN:INN]
- SU101
- 4-tert-butylbenzamide
- C12H9F3N2O2
- Leflunomide (Standard)
- LEFLUNOMIDE 1G
- Spectrum_000322
- CHEMBL960
- RefChem:55458
- DTXSID9023201
- 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
- SU-101
- AC1L1GYK
- AC1Q2EVA
- LEFLUNOMIDE [MI]
- Opera_ID_1709
- Prestwick0_000772
- Prestwick1_000772
- Prestwick2_000772
- Prestwick3_000772
- Spectrum5_000850
- G162GK9U4W
- HWA486
- LEFLUNOMIDE [JAN]
- Lopac-L-5025
- UNII-G162GK9U4W
- LEFLUNOMIDE [HSDB]
- LEFLUNOMIDE [USAN]
- D08ROP
- LEFLUNOMIDE 200MG
- HSDB 7289
- LEFLUNOMIDE [VANDF]
- L04AA13
- MLS000069648
- SCHEMBL5057
- CHEBI:6402
- DTXCID103201
- VHOGYURTWQBHIL-UHFFFAOYSA-N
- Aventis Brand of Leflunomide
- Hoechst Brand of Leflunomide
- LEFLUNOMIDE [MART.]
- BIDD:PXR0189
- Lopac0_000649
- MFCD00867593
- BSPBio_000844
- KBioSS_000802
- LEFLUNOMIDE [USP-RS]
- LEFLUNOMIDE [WHO-DD]
- Leflunomide, Immunosuppressant
- MLS001076267
- DivK1c_000916
- Leflunomide (JAN/USP/INN)
- NSC-677411
- NSC-759864
- SPECTRUM1503927
- SPBio_002783
- Leflunomide (JAN/USAN/INN)
- LEFLUNOMIDE [EMA EPAR]
- BPBio1_000930
- GTPL6825
- ISO054
- orb1309564
- ZINC4840
- Leflunomide, 98% - 1g 1g
- Leflunomide - Bio-X trade mark
- Leflunomide [USAN:USP:INN:BAN]
- RS-34821
- CTK8G0535
- ERK5-3M05
- HMS502N18
- HY-B0083R
- KBio1_000916
- KBio2_000802
- KBio2_003370
- KBio2_005938
- KS-00000KQI
- AOB5964
- CID3899
- LEFLUNOMIDE [EP IMPURITY]
- LEFLUNOMIDE [ORANGE BOOK]
- NINDS_000916
- NSC677411
- SU 101
- GLXC-06853
- HMS1570K06
- HMS1922M06
- HMS2090O12
- HMS2097K06
- HMS2235C07
- HMS3262A19
- HMS3268D12
- HMS3371F21
- HMS3414P03
- HMS3654F07
- HMS3673M17
- HMS3678N21
- HMS3714K06
- HMS3865I13
- HMS5079K21
- HMS6019D06
- LEFLUNOMIDE [EP MONOGRAPH]
- Leflunomide for peak identification
- Pharmakon1600-01503927
- 5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide
- 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
- LEFLUNOMIDE [USP MONOGRAPH]
- ALBB-019233
- Aventis Pharma Brand of Leflunomide
- BCP22241
- CID:3899
- EBD46417
- HY-B0083
- MSK10662
- PXB98723
- Leflunomide EPCRS (Y0000654)
- Tox21_110182
- Tox21_301873
- Tox21_500649
- 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
- ABP001076
- Aventis Behring Brand of Leflunomide
- BDBM50054601
- C12-H9-F3-N2-O2
- CL0019
- DL-433
- EBC-08359
- NCGC00015610-02
- NP3433
- NSC759864
- s1247
- STL426823
- SMR000058209
- 5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
- AKOS000265193
- alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
- Tox21_110182_1
- 4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-
- AC-6796
- AN-9632
- BCP9000846
- CCG-204736
- CS-1781
- DB01097
- FL16204
- KS-1076
- Leflunomide 100 microg/mL in Acetonitrile
- Leflunomide for peak identification CRS
- LP00649
- NSC 677411
- NSC 759864
- RP29613
- SB17287
- SDCCGSBI-0050629.P003
- CAS-75706-12-6
- IDI1_000916
- 5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)
- NCGC00015610-01
- NCGC00015610-03
- NCGC00015610-04
- NCGC00015610-05
- NCGC00015610-06
- NCGC00015610-07
- NCGC00015610-08
- NCGC00015610-09
- NCGC00015610-10
- NCGC00015610-11
- NCGC00015610-12
- NCGC00015610-13
- NCGC00015610-14
- NCGC00015610-17
- NCGC00015610-18
- NCGC00015610-30
- NCGC00022625-03
- NCGC00022625-04
- NCGC00022625-05
- NCGC00022625-06
- NCGC00022625-07
- NCGC00022625-08
- NCGC00255370-01
- NCGC00261334-01
- AJ-08231
- AK161855
- BC204155
- BM164612
- H527
- LS-86580
- SC-46541
- ST079287
- ZB000596
- 5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide
- L 5025
- SID:376229656
- AB0007396
- J227.599F
- TL8005179
- 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-
- A2852
- A9622
- AB00052389
- EU-0100649
- FT-0621959
- L0250
- Leflunomide, Arava, Leflunomidum, HWA-486
- N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide
- NS00003822
- R3926
- ST24047486
- SW196399-3
- AP-501/42475599
- N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
- 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide
- A10521
- C07905
- D00749
- EN300-119495
- MLS-0003109.0001
- AB00052389-17
- AB00052389-18
- AB00052389_19
- AB00052389_21
- Leflunomide =98.0% (by HPLC, total nitrogen)
- 706L126
- C045463
- F358076
- Q248550
- SR-01000000191
- A77 1486
- I06-2131
- SR-01000000191-2
- SR-01000000191-4
- SR-01000000191-7
- 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl
- 4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl)
- BRD-K78692225-001-03-9
- BRD-K78692225-001-11-2
- BRD-K78692225-001-22-9
- BRD-K78692225-001-23-7
- BRD-K78692225-001-24-5
- Leflunomide for peak identification CRS (Y0000674)
- D000077339
- Z228668542
- 5-methyl-4-(4-trifluoromethyl-phenyl)aminocarbonylisoxazole
- 5-methyl-4-(4-trifluoromethylphenyl)aminocarbonylisoxazole
- 5-METHYLISOXAZOLE-4-(4-TRIFLUOROMETHYLCARBOXANILID
- Leflunomide Working Standard (Secondary Reference Standard)
- Leflunomide, European Pharmacopoeia (EP) Reference Standard
- N-(4-(TRIFLUOROMETHYL)PHENYL) 5 METHYLISOXAZOLE-4-CARBOXAMIDE
- N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
- 4-Isoxazolecarboxamida, 5-metil-N-[4-(trifluorometil)fenil]-
- 5-methyl-n-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamid
- 5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide;
- 5-Methyl-N-[4-(trifluoromethyl)-phenyl]isoxazole-4-carboxamide
- 5-Methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4- carboxamide
- 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)-anilide
- N-(4-trifluoromethylphenyl)-5-methylisoxa-zole-4-carboxamide
- (5-methylisoxazol-4-yl)-N-[4-(trifluoromethyl)phenyl]carboxamide
- 5-methyl-N-(4-(trifluoromethyl)phenyl)-1,2-oxazole-4-carboxamide
- Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-
- Leflunomide, United States Pharmacopeia (USP) Reference Standard
- 1189987-23-2
- HWA486; RS-34821; SU101;HWA 486; RS 34821; SU 101
- Leflunomide, Pharmaceutical Secondary Standard; Certified Reference Material
- Leflunomide for peak identification, European Pharmacopoeia (EP) Reference Standard
- 616-254-6
- Leflunomide; 5-Methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide; Arava; HWA 486; Leflunomida; Leflunomidum; SU 101